EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the election of Robert P. Roche Jr. to the Company's Board of Directors… Dr. Smith has over 20 years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia, […] Mr. Greenleaf has over 20 years of biopharmaceutical experience, and currently serves as … GlobeNewswire. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella. Leonard S. Jacob, M.D., Ph.D., Chairman of the Board of Antares Pharma, stated, “We are pleased to announce the addition of a seasoned pharmaceutical executive to the Antares Board of Directors. Mr. Greenleaf has over 20 years of biopharmaceutical experience, and currently serves as the Chief Executive Officer of Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on … – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The board of directors of PhRMA includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. EWING, N.J., March 04, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat being vacated by the retirement of Dr. Jacques Gonella. Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors /EIN News/ -- EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. EWING, N.J., March 04, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat being vacated by the retirement of Dr. Jacques Gonella. Concurrently, Jack E. Stover has resigned as both Chief Executive Officer and Vice Chairman of the Board of Directors. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. EWING, N.J., Jan. 26, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to … See the breakdown of the total annual compensation for Karen L. Smith, M.D., Ph.D. for being a board member of ANTARES PHARMA INC, as well as other members of the Board of Directors for ANTARES PHARMA INC Antares Pharma, Inc. today announced the election of Marvin Samson to the Company's Board of Directors. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. EXHIBIT 99.1 ANTARES PHARMA ANNOUNCES THE APPOINTMENT OF PETER S. GREENLEAF TO COMPANY’S BOARD OF DIRECTORS EWING, N.J., December 13, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Antares Pharma Welcomes Marvin Samson to Board of Directors EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NAS: ATRS) today announced the election of Marvin Samson to the Company's EWING, N.J., March 04, 2019 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat being vacated by the retirement of Dr. Jacques Gonella. EWING, N.J., December 13, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Dr. Smith has over 20 years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia, and currently … EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced the election of Marvin Samson to the Company's Board of Directors. Mr. Samson is an expert in injectable manufacturing and... | October 7, 2020 Philippe has 20 years of experience in the life science industry, including pharma, biotech and med-tech companies. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Dr. Wotton joined Antares Pharma as President and Chief Operating Officer on July 7, 2008, having over 20 years of experience in the pharmaceutical industry with both large and specialty pharma companies. ANTARES PHARMA ANNOUNCES THE APPOINTMENT OF PETER S. GREENLEAF TO COMPANY’S BOARD OF DIRECTORS. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella, Stocks: ATRS, release date:Mar 04, 2019 Antares Pharma, Inc. (ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. Antares Pharma Appoints Dr. Karen Smith to Board of Directors and Announces Retirement of Dr. Jacques Gonella March 04 2019 - 07:00AM GlobeNewswire Inc. – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat being vacated by the retirement of Dr. Jacques Gonella. EWING, N.J., March 04, 2019 -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Dr. Karen Smith to the Company’s Board of Directors, filling the seat. Why Antares Pharma Inc. Shares Dove ... Wotton informed the board of directors of his resignation as CEO and from Antares' board of directors, as well … Antares Pharma Welcomes Robert P. Roche Jr. to Board of Directors EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NAS: ATRS) today announced the … Mr. Rubin was a member of the Executive Committee of the Board of Directors of The National Retail Federation from 2007 to 2010. The Board selected Mr. Rubin to serve as a Director based on his extensive managerial and operational knowledge of the retail industry and his experience as a board member of a specialty retailer. Board of Directors in ANTARES PHARMA INC. For its 2019 fiscal year, ANTARES PHARMA INC, listed the following board members on its annual proxy statement to the SEC. Dear Antares Board of Directors, As a shareholder of Antares Pharma (NASDAQ:ATRS) since December 2012, I am obviously not pleased with the … Name Total COMPENSATION; Anton G. Gueth: Total Cash $221,747: Jacques Gonella, Ph.D. Total Cash $7,500: Dr. Smith has over 20 years of biopharmaceutical industry experience in the United States, Europe, Canada and Asia, and currently … Prior to Ocata, he served as President and Chief Executive Officer and as a member of the board of directors of Antares Pharma, Inc., as Chief Executive Officer of Topigen Pharmaceuticals, and as the Global Head of Business Development of SkyePharma PLC. Ms. Hamill joined Acceleron’s board of directors in September 2020, bringing more than three decades of experience in the biopharma industry, serving most recently as Executive Vice President, Worldwide Commercial Operations at Gilead Sciences, Inc. Most recently, he was Chief Executive Officer and member of the Board of Directors of GlycoVaxyn for seven years. GlycoVaxyn was acquired by GSK in February 2015. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated , which was renamed to Ocata Therapeutics in November 2014. EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors.
Miles Morales Crash Ps4, Homebrew Vs Macports Vs Fink 2019, Nicosia Weather Radar, The River Lyrics Good Charlotte Meaning, When We're Human Karaoke, 70/30 Sink Vs 60/40, Myst Walkthrough Vr, Carolina Hurricanes Xm Radio, Wiac Fall Sports 2020,
